Tiffany Eul Davis Inglis is Chief Medical Officer of SERA PROGNOSTICS, INC.. Currently has a direct ownership of 75,000 shares of SERA, which is worth approximately $248,250. The most recent transaction as insider was on Oct 15, 2025, when has been sold 75,000 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75K
n/a 3M change
n/a 12M change
Total Value Held $248,250

Tiffany Eul Davis Inglis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 15 2025
BUY
Grant, award, or other acquisition
-
75,000 Added 50.0%
75,000 Class A Common Stock
TED

Tiffany Eul Davis Inglis

Chief Medical Officer
Salt Lake City, UT

Track Institutional and Insider Activities on SERA

Follow SERA PROGNOSTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SERA shares.

Notify only if

Insider Trading

Get notified when an Sera Prognostics, Inc. insider buys or sells SERA shares.

Notify only if

News

Receive news related to SERA PROGNOSTICS, INC.

Track Activities on SERA